Compugen
Compugen45
Compugen
Develops and commercializes novel drug candidates for oncology and immunology.
About
What does Compugen do?
Compugen is a clinical-stage drug discovery and development company focused on identifying and developing novel drug candidates for oncology and immunology. They utilize their proprietary discovery platforms to identify new biological targets and develop innovative therapies for unmet medical needs.
What is Compugen's revenue?
StartupHub estimates Compugen's annual revenue at $35.8M (range $20.0M to $43.6M, 64% confidence), based on comparable companies in the sector.
What is Compugen's valuation?
StartupHub estimates Compugen's effective valuation at $79.9M (range $55.9M to $103.9M, 26% confidence), based on comparable companies in the sector.
How much funding has Compugen raised?
Compugen has raised a total of $102M in funding. The most recent round on record is Funding Round.
Where is Compugen headquartered?
Compugen is headquartered in Tel Aviv, Israel.
When was Compugen founded?
Compugen was founded in 1993.
What industry does Compugen operate in?
Compugen operates in Oncology, Immunology, Life Sciences, Biotech, MedTech, HealthTech.
How many employees does Compugen have?
Compugen has approximately 112 people on record.
“Compugen Ltd. reported a significant financial turnaround in fiscal year 2025, achieving net profit and substantially increasing its cash position, bolstered by a $65 million non-dilutive payment from AstraZeneca, extending its cash runway…”
View on Reddit“Compugen Ltd. reported strong fourth quarter and full year 2025 financial results, driven by a $65 million non-dilutive royalty monetization deal with AstraZeneca that extends its cash runway into 2029.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.